Researchers at MedUni Vienna have developed a combination therapy using systemic interferon-I and topical imiquimod.

A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

This medicine also destroys genital warts. Some patients, however, continue to get new AKs, skin cancers, or genital warts. Imiquimod can destroy a tumor or wart — but not its cause. What causes AKs ...